1. Home
  2. BZUN vs ABOS Comparison

BZUN vs ABOS Comparison

Compare BZUN & ABOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Baozun Inc.

BZUN

Baozun Inc.

HOLD

Current Price

$2.15

Market Cap

157.7M

ML Signal

HOLD

Logo Acumen Pharmaceuticals Inc.

ABOS

Acumen Pharmaceuticals Inc.

HOLD

Current Price

$2.71

Market Cap

155.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BZUN
ABOS
Founded
2007
1996
Country
China
United States
Employees
N/A
N/A
Industry
Catalog/Specialty Distribution
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
157.7M
155.7M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
BZUN
ABOS
Price
$2.15
$2.71
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$7.75
AVG Volume (30 Days)
219.7K
473.4K
Earning Date
03-25-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$6.10
N/A
Revenue Next Year
$3.93
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.11
$0.86
52 Week High
$4.88
$3.60

Technical Indicators

Market Signals
Indicator
BZUN
ABOS
Relative Strength Index (RSI) 25.01 41.76
Support Level N/A $1.21
Resistance Level $3.05 $3.05
Average True Range (ATR) 0.10 0.26
MACD -0.02 -0.10
Stochastic Oscillator 8.75 7.73

Price Performance

Historical Comparison
BZUN
ABOS

About BZUN Baozun Inc.

Baozun Inc is engaged to provide its customers with end-to-end e-commerce solutions including the sales of apparel, home and electronic products, online store design and setup, visual merchandising and marketing, online store operations, customer services, warehousing and order fulfillment, as well as the holistic brand management, including strategy and tactic positioning, branding and marketing, retail and e-commerce operations, supply chain and logistics, and technology empowerment. It has two operating segments: E-Commerce (encompassing BEC and BZI) and Brand Management (representing BBM). The company generates maximum of its revenue from E-Commerce (encompassing BEC and BZI) segment.

About ABOS Acumen Pharmaceuticals Inc.

Acumen Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing a novel disease-modifying approach to target what it believes to be a key underlying cause of Alzheimer's disease. The company's drug candidate, ACU193, is a subclass monoclonal antibody that selectively targets amyloid-beta oligomers.

Share on Social Networks: